rs878854103

Variant names:

• chr16-2084292-T-A
• rs878854103
• NM_000548.5:c.4070T>A

Your query was ambiguous. Multiple possible variants found:

• chr16-2084292-T-A
• chr16-2084292-T-C

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2 BP6

The NM_000548.5(TSC2):​c.4070T>A​(p.Ile1357Asn) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I1357L) has been classified as Likely benign.

• Frequency: Genomes: not found (cov: 34)
• Consequence: TSC2 NM_000548.5 missense
• Clinical Significance: Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1 B:1
• Conservation: PhyloP100: 7.17
• Publications: 0 publications found

Genes affected

TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]

TSC2 Gene-Disease associations (from GenCC):

• tuberous sclerosis

  Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
• tuberous sclerosis 2

  Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics
• lymphangioleiomyomatosis

  Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
• tuberous sclerosis complex

  Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

ACMG classification

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

• PM2: Very rare variant in population databases, with high coverage
• BP6: Variant 16-2084292-T-A is Benign according to our data. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042. Variant chr16-2084292-T-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 238042.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
TSC2	NM_000548.5	c.4070T>A	p.Ile1357Asn	missense_variant	Exon 34 of 42	ENST00000219476.9	NP_000539.2

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
TSC2	ENST00000219476.9	c.4070T>A	p.Ile1357Asn	missense_variant	Exon 34 of 42	5	NM_000548.5	ENSP00000219476.3

Frequencies

GnomAD3 genomes Cov.: 34

GnomAD2 exomes AF: 0.00000405 AC: 1 AN: 246836 AF XY: 0.00000745

Gnomad AFR exome AF: 0.00

Gnomad AMR exome AF: 0.00

Gnomad ASJ exome AF: 0.00

Gnomad EAS exome AF: 0.0000546

Gnomad FIN exome AF: 0.00

Gnomad NFE exome AF: 0.00

Gnomad OTH exome AF: 0.00

GnomAD4 exome Cov.: 33

GnomAD4 genome Cov.: 34

ClinVar

Significance: Conflicting classifications of pathogenicity

Submissions summary: Uncertain:1 Benign:1

Revision: criteria provided, conflicting classifications

Submissions by phenotype

Hereditary cancer-predisposing syndrome Uncertain:1

Mar 12, 2023

Ambry Genetics

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

The p.I1357N variant (also known as c.4070T>A), located in coding exon 33 of the TSC2 gene, results from a T to A substitution at nucleotide position 4070. The isoleucine at codon 1357 is replaced by asparagine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Tuberous sclerosis 2 Benign:1

Oct 29, 2024

Labcorp Genetics (formerly Invitae), Labcorp

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
AlphaMissense	Benign	0.28
BayesDel_addAF	Pathogenic	0.20	D
BayesDel_noAF	Pathogenic	0.22
CADD	Uncertain	24
DANN	Uncertain	0.99
DEOGEN2	Uncertain	0.60	D;.;.;.;.;.;.;.;.;.;.;.;T;.;T
Eigen	Uncertain	0.37
Eigen_PC	Uncertain	0.32
FATHMM_MKL	Pathogenic	0.99	D
LIST_S2	Uncertain	0.97	D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
M_CAP	Pathogenic	0.62	D
MetaRNN	Uncertain	0.69	D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM	Pathogenic	0.80	D
MutationAssessor	Uncertain	2.3	M;.;.;.;.;.;.;.;.;.;.;.;.;.;.
PhyloP100		7.2
PrimateAI	Uncertain	0.62	T
PROVEAN	Uncertain	-2.8	D;.;.;N;.;N;.;.;N;N;.;.;.;.;N
REVEL	Uncertain	0.55
Sift	Uncertain	0.0010	D;.;.;D;.;D;.;.;D;D;.;.;.;.;D
Sift4G	Uncertain	0.0080	D;.;.;D;.;D;.;.;D;T;.;.;.;.;D
Polyphen		0.99	D;.;.;.;D;D;.;.;D;D;.;.;.;.;.
Vest4		0.80
MutPred		0.28		Loss of stability (P = 0.1024);.;.;.;.;.;.;Loss of stability (P = 0.1024);.;.;.;.;.;.;.;
MVP		0.87
ClinPred		0.96	D
GERP RS		4.8
RBP_binding_hub_radar		0.0
RBP_regulation_power_radar		1.1
Varity_R		0.52
gMVP		0.69
Mutation Taster		=60/40	polymorphism

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs878854103; hg19: chr16-2134293;